REVB: Revelation Biosciences Company Short-Term Debt
Patient safety at Revelation Biosciences (REVB) is ensured through strict control over the transportation of clinical trial components. A narrow focus on immunology creates a significant dependence on regulatory verdicts, which amplifies the risks associated with a single-product model. The visualization of the price trend, where the metric is 0.00, complements revenue data that will be based on the sale of treatments for inflammation and respiratory tract infections.
Metric breakdowns and analytics for Revelation Biosciences Corp (REVB)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Revelation Biosciences|REVB - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Revelation Biosciences|REVB - Company Total Debt|Debt to Book Capitalization Ratio Revelation Biosciences, Inc.|REVB - Company Long-Term Liabilities|Company Current Liabilities Revelation Biosciences|Quick Liquidity revbiosciences.com
- net income and valuation multiples indicators:
Initial company analysis:REVB - Revelation Biosciences, Inc.
Analyzing the change in short-term loan amounts on the GURU.Markets platform, an investor assesses the obligations of Revelation Biosciences (REVB) with maturities of up to one year, which is critical for maintaining liquidity amid non-cyclical R&D funding. This indicator aggregates current accounts payable, where a moderate reduction in debt strengthens financial stability, while excessive contraction could limit the working capital necessary to conduct clinical trials.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|UPB - Company Short-Term Debt|Company Short-Term Loans and Borrowings ZBIO (Zenas Corp)|IMNM: Company Short-Term Debts|Short-Term Debt gossamerbio.com (GOSS)|Company Current Liabilities KALV|Company Short-Term Debt SEPN|Company Short-Term Debts PVLA|SVRA - Short-Term Debt|Company Short-Term Debt Rigel Pharmaceuticals RIGL|anaptysbio.com - Company Short-Term Debt|Astria Therapeutics, Inc. - Company Short-Term Debts|ENGN - Company Short-Term Debts|RAPT (RAPT Therapeutics) - Company Current Liabilities|JBIO: Amount of Current Liabilities|ACRS (Aclaris Therapeutics) - Company Short-Term Debts|kyvernatx.com (KYTX) - Short-Term Debt Volume|Company Short-Term Debt Tiziana Life Sciences Ltd (TLSA)|CABA - Short-Term Debt|Company Short-Term Debt Ventyx Bio VTYX|THTX: Company Short-Term Indebtedness|AVTX: Company Current Liabilities|Company Short-Term Loans and Borrowings ELDN (eledon.com)|AGEN: Company Short-Term Debts|CLYM (Climb Bio Inc.) - Company Short-Term Debt|ZURA (Zura Bio) - Company Short-Term Debts|aTyr Pharmaceuticals (ATYR) - Short-Term Debt Volume|Company Short-Term Debt Adagene (ADAG)|IMA - Short-Term Debt|Company Short-Term Debt Shattuck Labs STTK|Short-Term Debt Volume Equillium Inc (EQ)|Connect Pharma - Company Short-Term Debts|Immunic, Inc. (IMUX) - Company Current Liabilities|ATRA: Company Short-Term Debts|IFRX - Short-Term Debt Volume|XFOR (X4 Pharmaceuticals, Inc.) - Company Short-Term Debts|Short-Term Debt Adicet ACET|Company Short-Term Debt Celularity Inc. (CELU)|INmune Bio Corporation - Company Short-Term Indebtedness|Company Short-Term Debts BRNS (Barinthus Biotherapeutics)|KZR - Company Current Liabilities|SAB Biotherapeutics, Inc. - Company Short-Term Debts|Short-Term Debt Akari Therapeutics PLC|enlivex.com (ENLV) - Company Short-Term Debt|QTTB - Short-Term Debt Volume|Company Short-Term Debt GeoVax Labs, Inc.|EDSA: Company Short-Term Loans and Borrowings|Company Short-Term Debts IBIO|CARM - Short-Term Debt|XTL Biopharmaceuticals, Ltd. - Company Current Liabilities|Bolt Biotherapeutics Inc. - Company Short-Term Debt|HCW Biologics Inc - Company Short-Term Debts|APVO: Company Short-Term Debt|AIM ImmunoTech Inc. (AIM) - Company Short-Term Debt|Current Liabilities ADTX (Aditxt, Inc.)|GRI (GRI Bio Corp) - Company Short-Term Debts|XRTX: Company Short-Term Loans and Borrowings|Company Short-Term Debts HIND|Company Short-Term Debts indaptusrx.com (INDP)|Company Short-Term Debt Scinai Immunotherapeutics Ltd. SCNI|Company Short-Term Loans and Borrowings CALI|AFMD - Company Short-Term Debt|Allakos Inc. (ALLK) - Company Current Liabilities|HOOK: Company Short-Term Debts|IGM Biosciences (IGMS) - Company Short-Term Debts|Company Current Liabilities ITOS|OCEA: Company Short-Term Loans and Borrowings|Company Short-Term Debts TCBP|Short-Term Debt Volume Third Harmonic Bio Inc